These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 17890112)

  • 1. Mechanisms in experimental venous valve failure and their modification by Daflon 500 mg.
    Pascarella L; Lulic D; Penn AH; Alsaigh T; Lee J; Shin H; Kapur V; Bergan JJ; Schmid-Schönbein GW
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):102-10. PubMed ID: 17890112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension-induced venous valve remodeling.
    Takase S; Pascarella L; Bergan JJ; Schmid-Schönbein GW
    J Vasc Surg; 2004 Jun; 39(6):1329-34. PubMed ID: 15192576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An animal model of venous hypertension: the role of inflammation in venous valve failure.
    Pascarella L; Schmid-Schönbein GW; Bergan J
    J Vasc Surg; 2005 Feb; 41(2):303-11. PubMed ID: 15768014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous hypertension, inflammation and valve remodeling.
    Takase S; Pascarella L; Lerond L; Bergan JJ; Schmid-Schönbein GW
    Eur J Vasc Endovasc Surg; 2004 Nov; 28(5):484-93. PubMed ID: 15465369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of primary chronic venous disease: Insights from animal models of venous hypertension.
    Bergan JJ; Pascarella L; Schmid-Schönbein GW
    J Vasc Surg; 2008 Jan; 47(1):183-92. PubMed ID: 18178472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rat femoral arteriovenous fistula model: increased expression of matrix metalloproteinase-2 and -9 at the venous stenosis.
    Misra S; Fu AA; Anderson JL; Sethi S; Glockner JF; McKusick MA; Bjarnason H; Woodrum DA; Mukhopadhyay D
    J Vasc Interv Radiol; 2008 Apr; 19(4):587-94. PubMed ID: 18375305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remodeling of experimental arteriovenous fistula with increased matrix metalloproteinase expression in rats.
    Chan CY; Chen YS; Ma MC; Chen CF
    J Vasc Surg; 2007 Apr; 45(4):804-11. PubMed ID: 17398390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanosensitive transient receptor potential vanilloid type 1 channels contribute to vascular remodeling of rat fistula veins.
    Chen YS; Lu MJ; Huang HS; Ma MC
    J Vasc Surg; 2010 Nov; 52(5):1310-20. PubMed ID: 20638226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibition limits arterial enlargements in a rodent arteriovenous fistula model.
    Abbruzzese TA; Guzman RJ; Martin RL; Yee C; Zarins CK; Dalman RL
    Surgery; 1998 Aug; 124(2):328-34; discussion 334-5. PubMed ID: 9706156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From symptoms to leg edema: efficacy of Daflon 500 mg.
    Nicolaides AN
    Angiology; 2003; 54 Suppl 1():S33-44. PubMed ID: 12934755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inflammatory reaction during venous hypertension in the rat.
    Takase S; Lerond L; Bergan JJ; Schmid-Schönbein GW
    Microcirculation; 2000 Feb; 7(1):41-52. PubMed ID: 10708336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [External valvuloplasty of the sapheno-femoral junction].
    Corcos L; Peruzzi GP; Romeo V; Procacci T; Zamboni P; Dini S
    Phlebologie; 1991; 44(2):497-508. PubMed ID: 1946687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micronized purified flavonoid fraction (MPFF): a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency.
    Katsenis K
    Curr Vasc Pharmacol; 2005 Jan; 3(1):1-9. PubMed ID: 15641940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension.
    Lalka SG; Unthank JL; Nixon JC
    J Surg Res; 1998 Jan; 74(1):59-63. PubMed ID: 9536975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone preserves vein graft integrity in a rat aortic interposition model.
    Chen Z; Hasegawa T; Tanaka A; Okita Y; Okada K
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):408-416.e1. PubMed ID: 20189191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic microangiopathy using O-(beta-hydroxyethyl)-rutosides: a prospective comparative clinical registry.
    Belcaro G; Cesarone MR; Ledda A; Cacchio M; Ruffini I; Ricci A; Ippolito E; Di Renzo A; Dugall M; Corsi M; Marino Santarelli AR; Grossi MG
    Angiology; 2008; 59 Suppl 1():14S-20S. PubMed ID: 18287163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
    Kakkos SK; Nicolaides AN
    Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Micronized Purified Flavonoid Fraction (MPFF) on a Novel Experimental Model of Chronic Venous Hypertension.
    das Graças C de Souza M; Cyrino FZ; de Carvalho JJ; Blanc-Guillemaud V; Bouskela E
    Eur J Vasc Endovasc Surg; 2018 May; 55(5):694-702. PubMed ID: 29588131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a porcine model of chronic superficial varicose veins.
    Jones GT; Grant MW; Thomson IA; Hill BG; van Rij AM
    J Vasc Surg; 2009 Jun; 49(6):1554-61. PubMed ID: 19497519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RELIEF study: first consolidated European data. Reflux assEssment and quaLity of lIfe improvement with micronized Flavonoids.
    Jantet G
    Angiology; 2000 Jan; 51(1):31-7. PubMed ID: 10667641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.